phosphorus has been researched along with mdl 100907 in 1 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 1,241 | 65 | 539 |
Protein | Taxonomy | phosphorus (IC50) | mdl 100907 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, H; Hasegawa, T; Hotta, Y; Ishikawa, N; Miki, Y; Miyazeki, K; Muto, T; Sugimoto, Y; Yamada, J | 1 |
1 other study(ies) available for phosphorus and mdl 100907
Article | Year |
---|---|
Protective effects of sarpogrelate, a 5-HT2A antagonist, against postischemic myocardial dysfunction in guinea-pig hearts.
Topics: Animals; Calcium; Calcium Signaling; Cardiotonic Agents; Free Radical Scavengers; Free Radicals; Fura-2; Guinea Pigs; In Vitro Techniques; Mitochondria, Heart; Myocardial Contraction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide; Phosphorus; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Succinates | 2005 |